• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用肝功能检测对肝硬化患者进行肝细胞癌的诊断。

Diagnosis of hepatocellular carcinoma in patients with liver cirrhosis using liver function assays.

作者信息

Itoshima T, Kawaguchi K, Ukida M, Ito T, Hattori S, Kitadai M, Ogawa H, Mizutani S, Kita K, Tanaka R

出版信息

Acta Med Okayama. 1984 Apr;38(2):159-68. doi: 10.18926/AMO/30328.

DOI:10.18926/AMO/30328
PMID:6203337
Abstract

Sex, age and 21 routine liver function assays were analyzed by stepwise selection and the best-of-all-possible-combinations method to identify a small group of assays valuable in establishing which liver cirrhosis (LC) patients have a high risk of hepatocellular carcinoma (HCC), when alpha-fetoprotein (AFP) is not elevated. Data was obtained from 115 HCC and 122 LC patients on admission. Tumor size correlated with AFP (0.73), alkaline phosphatase (ALP, 0.47), leucine aminopeptidase (LAP, 0.42), lactic dehydrogenase (LDH, 0.42), and the glutamic oxaloacetic transaminase (GOT)/glutamic pyruvic transaminase (GPT) ratio (GOT/GPT, 0.41). The mean of the correct diagnosis rates (CDR) of HCC and LC utilizing AFP as the sole parameter (89%) was markedly higher than those of the other parameters. The best-of-all-possible-combinations method presented a more powerful combination than stepwise selection. The best combination of 7 parameters (LAP, GOT/GPT, choline esterase, one-hour erythrocyte sedimentation rate, age, albumin/globulin ratio, and total bilirubin) presented a mean CDR of 80%, HCC CDR of 77%, and false positive rate of 18%. LC patients statistically diagnosed as having HCC by these 7 parameters are proposed as high risk patients. Fourteen (78%) of 18 HCC patients who were AFP-negative were statistically diagnosed. This analysis can be applied to LC patients to distinguish those that should be followed closely by imaging diagnostic techniques.

摘要

通过逐步选择和所有可能组合中的最佳组合方法,对性别、年龄和21项常规肝功能检测进行分析,以确定一小部分在甲胎蛋白(AFP)未升高时,对判断哪些肝硬化(LC)患者有肝细胞癌(HCC)高风险有价值的检测项目。数据来自115例HCC患者和122例LC患者入院时的情况。肿瘤大小与AFP(0.73)、碱性磷酸酶(ALP,0.47)、亮氨酸氨基肽酶(LAP,0.42)、乳酸脱氢酶(LDH,0.42)以及谷草转氨酶(GOT)/谷丙转氨酶(GPT)比值(GOT/GPT,0.41)相关。以AFP作为唯一参数时,HCC和LC的正确诊断率(CDR)均值(89%)明显高于其他参数。所有可能组合中的最佳组合方法比逐步选择法呈现出更强有力的组合。7个参数(LAP、GOT/GPT、胆碱酯酶、一小时红细胞沉降率、年龄、白蛋白/球蛋白比值和总胆红素)的最佳组合呈现出的CDR均值为80%,HCC的CDR为77%,假阳性率为18%。通过这7个参数被统计学诊断为HCC的LC患者被提议作为高风险患者。18例AFP阴性的HCC患者中有14例(78%)被统计学诊断。该分析可应用于LC患者,以区分那些应通过影像诊断技术密切随访的患者。

相似文献

1
Diagnosis of hepatocellular carcinoma in patients with liver cirrhosis using liver function assays.使用肝功能检测对肝硬化患者进行肝细胞癌的诊断。
Acta Med Okayama. 1984 Apr;38(2):159-68. doi: 10.18926/AMO/30328.
2
Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.γ-谷氨酰转肽酶与碱性磷酸酶比值、γ-谷氨酰转肽酶与天冬氨酸氨基转移酶比值和丙氨酸氨基转移酶与天冬氨酸氨基转移酶比值联合对甲胎蛋白阴性肝细胞癌的诊断价值。
Cancer Med. 2021 Jul;10(14):4844-4854. doi: 10.1002/cam4.4057. Epub 2021 Jun 18.
3
The value of liver function tests in hepatocellular carcinoma.肝功能检查在肝细胞癌中的价值。
Malays J Pathol. 1996 Dec;18(2):95-9.
4
Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinoma.肝细胞癌中血清谷草转氨酶/谷丙转氨酶比值
Cancer. 1977 Jul;40(1):319-24. doi: 10.1002/1097-0142(197707)40:1<319::aid-cncr2820400145>3.0.co;2-q.
5
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.肝癌患者甲胎蛋白水平的决定因素:对其临床应用的影响。
Cancer. 2014 Jul 15;120(14):2150-7. doi: 10.1002/cncr.28706. Epub 2014 Apr 10.
6
Estimation of leucine aminopeptidase and 5-nucleotidase increases alpha-fetoprotein sensitivity in human hepatocellular carcinoma cases.
Asian Pac J Cancer Prev. 2015;16(3):959-63. doi: 10.7314/apjcp.2015.16.3.959.
7
Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.分类树和神经网络算法在肝细胞癌诊断血清学肝脏标志物谱识别中的应用。
Oncology. 2001;61(4):275-83. doi: 10.1159/000055334.
8
Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.血清IV型胶原蛋白在肝癌以及肝硬化中均有升高。
Anticancer Res. 1995 Nov-Dec;15(6B):2777-80.
9
[Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].血清甲胎蛋白(AFP)作为丙型肝炎病毒相关性肝硬化中肝细胞癌(HCC)标志物的有用性:对不发生HCC情况下AFP升高的影响因素分析
Korean J Gastroenterol. 2006 Nov;48(5):321-6.
10
Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.甲胎蛋白在肝细胞癌诊断中的效用。
Anticancer Res. 2003 Mar-Apr;23(2C):1747-53.

引用本文的文献

1
Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival.对台湾南部6381例肝细胞癌患者的分析:预后特征、治疗结果及生存情况
J Gastroenterol. 2008;43(2):159-70. doi: 10.1007/s00535-007-2134-9. Epub 2008 Feb 29.